9. Cardiovascular Disease and Risk Management

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)

James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial

Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728

Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet

Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638

Management of Hypertension in Diabetes Mellitus

Doumas, M. N., & Bakris, G. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-92946-0_7

MESA 3: DIABETES MELLITUS TIPO 2 Y ACTIVIDAD FÍSICA

Buso, C. J., Ávila, P. J., Bertollo, N., Martín, C. G., Dios, A. D., Fábregues, S., González, L., Lobbe, V., Mumbach, G., Retamosa, J., et al. (2018) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v52i3sup.124

DIABETE, TABAGISMO E DISASSUEFAZIONE DAL FUMO

Campagna, D., Alamo, A., Mondati, E. G. M., & Polosa, R. (2019) · il Diabete · doi:10.30682/ildia1901d

Impact of Endocrine Disorders on Blood Pressure

Carbone, F., Bonaventura, A., Liberale, L., Vecchié, A., Casula, M., Dallegri, F., & Montecucco, F. (2019) · Endocrinology · doi:10.1007/978-3-319-66362-3_2-1

Statin Use and the Point Prevalence of Antibiotics in Ambulatory Patients with Diabetes in the National Health and Nutrition Examination Survey (NHANES) 2003–2012

Alarfaj, S. J., Pérez, A., & Unger, N. R. (2019) · Antibiotics · doi:10.3390/antibiotics8020064

Differences of Hypertension in the Case of Controlled and Uncontrolled Diabetes Mellitus Type 2 In Pirngadi General Hospital Medan

Sitepu, R., Tarigan, E., Yustina, I., & Santoso, H. (2020) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt20jul433

Relationship between Hypertension and the Declining Renal Function in Korean Adults

Lee, J. H. (2021) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2021.53.1.32

Influence of sodium intake and sociodemographic, lifestyle and anthropometric variables on blood cholesterol of hypertensive women

Padilha, B. M., Vasconcelos, S. M. L., Cabral, P. C., Wanderley, T. M., Gomes, A. D. S., Gaia, J. A., & Rodrigues, L. A. (2021) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.rmrp.2021.170618

Diabetes in Older Adults

Hudson, M., & Palermo, N. E. (2020) · Springer eBooks · doi:10.1007/978-3-319-47771-8_14

Cardiovascular Risk Factors and Peripheral Arterial Disease

Daskalopoulou, S. S., & Mikhailidis, D. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-65936-7_17

Faculty Opinions recommendation of Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure.

Aschner, P. J. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727299606.793538292

Session Three: Innovating Beyond Glucose Control in Diabetes Care

Michel, L. (2017) · EMJ Diabetes · doi:10.33590/emjdiabet/10314488

Evaluation of Some Parameters to Detection of Type 2 Diabetes Induced Nephropathy in the Population Sample of Al Dewaniyah Province

Jasim, R. H., & Khulaibus, M. A. (2023) · Journal of Kufa for Chemical Sciences · doi:10.36329/jkcm/2023/v2.i10.13552

A Review of Arrhythmias in Endocrinology

Ram, N., & Salik, M. (2023) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_17_23 · Cited by 1

Modulatory effect of aqueous leaf extract of Terminalia catappa on dyslipidemia in alloxan induced diabetic rats

Ben, E. E., Asuquo, A. E., & Umoh, C. O. (2024) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2024.21.2.0337

Pharmacotherapy of Chronic Diseases (e.g., Diabetes, Hypertension)

Kathuria, M. (2019) · The Pharma Innovation · doi:10.22271/tpi.2019.v8.i1n.25490

Chapter 3: Prevention and Risk Reduction

Cypress, M., & Tomky, D. M. (2017) · American Diabetes Association eBooks · doi:10.2337/9781580405690.ch03

Pengetahuan dan Praktik Pengelolaan Obat pada Lansia Penderita Hipertensi Dengan dan Tanpa Diabetes Melitus dengan Status Polifarmasi

Fitria, N., Hidayat, M. A. P., Wati, E. A., Fathikasari, A. C., Adella, M. J. F., Rahmadani, J. A., Nafisah, N., Akbar, J. A., Rahmawati, M., Baehaki, M. H. W., et al. (2024) · Jurnal Farmasi Komunitas · doi:10.20473/jfk.v11i2.52653

Nano-phytocompound Combats Food Additive-Induced Genotoxicity and Mitochondrial Dysfunction in Diabetic Model: An In Silico Predicted Experimental Study

Dey, S., Guptaroy, P., & Samadder, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-75457-9_7

Factors Involved in the Progression of Preclinical Atherosclerosis in People with Type 1 Diabetes

Viñals, C., Conget, I., Granados, M., Solà, C., Ayala, D., Mesa, A., Serés‐Noriega, T., Doménech, M., Perea, V., Blanco, J., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176004 · Cited by 1

Dapagliflozin Alone or Combined with Semaglutide

Alharajin, R., AlTaweel, M., AlSubaiee, M., Almekhloof, S., Almusaad, A., Alarfaj, A. A., Alkhayyal, A. K., Altharman, N. M., Alalawi, A., Almannai, N., et al. (2026) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.041.02.6171

Trends in utilization of glucagon-like peptide‑1 receptor agonists, sodium–glucose cotransporter‑2 inhibitors, and metabolic bariatric surgery in U.S. adults with diabetes and obesity

Wartko, P. D., Zhang, R., Johnson, E., Begle, C., Bobb, J. F., Chen, C., Singh, A., ROSS, L. C., O’Connor, P. J., Arterburn, D. E., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113504

Improved Management of Type 2 Diabetes Mellitus with Empigliflozin and Hypertension with Renin-Angiotensin System Inhibitors and Manidipine, Preferentially of Dihydropyridones to Optimize Cardiovascular Outcomes

Kaur, M. K. K., MD, D. G. A., & MD, D. M. S. (2025) · Obesity Research - Open Journal · doi:10.17140/oroj.2025.v11.i01.pp01-13.1425

8. Cardiovascular Disease and Risk Management

American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc15-s011 · Cited by 239

Section 10: Cardiovascular Disease and Risk Management

(2025) · Clinical Diabetes · doi:10.2337/cd25-a010 · Cited by 1

Chapter 17: Cardiovascular Disease and Risk Management

(2022) · American Diabetes Association eBooks · doi:10.2337/9781580408172.ch17

Managing Cardiovascular Disease and Events in the Patient with Diabetes

Wyne, K. L. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-0273-4.50020-5 · Cited by 1

Topics in Cardiovascular Disease and Diabetes

Bloomgarden, Z. T. (1997) · Diabetes Care · doi:10.2337/diacare.20.10.1624 · Cited by 4